Nevertheless, colchicine therapy did not significantly reduce cardiovascular mortality in these trials and was associated with an almost significant increase in non-cardiovascular mortality in LoDoCo2 ( 220 ).
← all excerpts
Immunotherapeutic Strategies in Cancer and Atherosclerosis-Two Sides of the Same Coin.
1
—
—